Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: RX BANDZ, INC.
Awarding agency: Department of Defense / Department of the Air Force
Funding agency: Department of Defense / Department of the Air Force
Period of performance: 2023-09-18 to 2025-09-18
Current total value of award: $1799613.4
Description: MEDICAL RESEARCH AND DEVELOPMENT - SBIR II TACFI - AUTO-INJECTOR COMMERCIALIZATION